| 发明名称 |
COMPOSITION AND USE OF LACTOBACILLUS REUTERI GMNL-263 IN DECREASING BLOOD LIPID LEVELS |
| 摘要 |
A use of a Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels is disclosed. Lactobacillus reuteri GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factor and lipid synthesis and promotes gene expression related to cholesterol metabolism. Lactobacillus reuteri GMNL-263 is utilized to produce a composition for decreasing blood lipid levels, thereby achieving the aim of hyperlipidemia treatment. |
| 申请公布号 |
US2016095889(A1) |
申请公布日期 |
2016.04.07 |
| 申请号 |
US201514618188 |
申请日期 |
2015.02.10 |
| 申请人 |
GENMONT BIOTECH INC. |
发明人 |
CHEN YI-HSING;CHEN YA-HUI;LOU TZU-CHI;SHEN TING-YUN |
| 分类号 |
A61K35/747;A23L1/30 |
主分类号 |
A61K35/747 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A probiotics composition for decreasing blood lipid levels, comprising:
a therapeutically effective amount of Lactobacillus reuteri GMNL-263 (deposited at the China Center for Type Culture Collection of Wuhan University in China under accession No.: CCTCC M 209263) to specifically inhibit gene expression related to pro-inflammatory factor and lipid synthesis and to promote gene expression related to cholesterol metabolism, achieving the aim of decrease of blood lipid levels. |
| 地址 |
Tainan City TW |
